Washington State Fund Pumps $3.7M into Personalized Medicine, Protein Studies | GenomeWeb

NEW YORK (GenomeWeb News) – Washington State's Life Sciences Discovery Fund has awarded approximately $3.7 million to fund regional research projects that aim to develop and use genomic and protein-based technologies for use in personalized diagnostics and therapeutics.

LSDF, funded by the Master Tobacco Settlement Agreement, said yesterday that it has awarded $2.4 million in funding under its Opportunity Grants program to support two large-scale research and development programs, and $1,250,000 to fund several proof-of-concept projects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.